Haystack Oncology

Haystack Oncology, Inc. is built on over 20 years of liquid biopsy technology and clinical development, led by scientists specializing in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease treatment monitoring. Their discoveries have positively impacted the lives of millions, and companies utilizing their technology have created billions of dollars in enterprise value.